London: The ongoing fight against the coronavirus has received a major setback. A person involved in the human trial of AstraZeneca and the Oxford University Vaccine (Oxford COVID-19 Vaccine) has been stopped after falling ill. AstraZeneca has issued a statement saying that this is a routine interruption, as nothing is yet understood about the illness of the person involved in the testing.
The vaccine was named AZD1222. According to the World Health Organization (WHO), it was leading in comparison to other vaccine trials in the world. Many countries, including India, are eyeing the Oxford University vaccine. Experts believe that there is a lot of hope that Oxford University will be among the first vaccine to come in the market.
According to an AFP news, the ongoing trial has been stopped all over the world and now it can be resumed only after an independent investigation. Thousands of people are involved in the third phase of the vaccine trial, and it often takes many years. The third phase trial of the corona vaccine involves close to 30,000 people.
A spokesman for Oxford University said, “There is every possibility of falling ill in a large trial, but independent vetting is very important to check it carefully.” Let it be said that this is the second time when the trial of Corona virus vaccine has been stopped at Oxford University.
